Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18755013 | 0.82 | TSHR (0.54) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL27686070 | 0.78 | TSHR (0.45) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL29531590 | 0.77 | TSHR (0.48) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL799424 | 0.77 | TSHR (0.48) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL8525778 | 0.76 | TSHR (0.46) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL27932115 | 0.75 | TSHR (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL372689 | 0.74 | — | — | |
| SCHEMBL24652900 | 0.74 | TSHR (0.45) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL7719555 | 0.74 | TSHR (0.45) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL10751530 | 0.74 | ZDHHC20 (0.47) | TSHRALDH1A1MAPK1TDP1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190338010-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2019-11-07 | — | — | US | disclosed |
| US-10358471-B2 | Fusion proteins of collagen-binding domain and parathyroid hormone | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2019-07-23 | — | — | US | disclosed |
| US-10202434-B2 | Fusion proteins of collagen-binding domain and parathyroid hormone | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2019-02-12 | — | — | US | disclosed |
| EP-3091075-B1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | UNIV ARKANSAS (US) | 2018-06-13 | — | — | EP | disclosed |
| US-20170101457-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | OCHSNER CLINIC FOUNDATION (US) | 2017-04-13 | — | — | US | disclosed |
| EP-2582427-B1 | PHOTODYNAMIC BONE STABILIZATION AND DRUG DELIVERY SYSTEMS | ILLUMINOSS MEDICAL INC (US) | 2015-09-30 | — | — | EP | disclosed |
| US-9062300-B2 | Fusion proteins of collagen-binding domain and parathyroid hormone | NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) | 2015-06-23 | — | — | US | disclosed |
| US-20130337017-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) | 2013-12-19 | — | — | US | disclosed |
| US-8450273-B2 | Fusion proteins of collagen-binding domain and parathyroid hormone | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2013-05-28 | — | — | US | disclosed |
| EP-2582427-A1 | PHOTODYNAMIC BONE STABILIZATION AND DRUG DELIVERY SYSTEMS | Illuminoss Medical, Inc. (US) | 2013-04-24 | — | — | EP | disclosed |
| WO-2011162910-A1 | PHOTODYNAMIC BONE STABILIZATION AND DRUG DELIVERY SYSTEMS | ILLUMINOSS MEDICAL, INC. (US) | 2011-12-29 | — | — | WO | disclosed |
| US-20100129341-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | OCHSNER CLINIC FOUNDATION | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129341-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | PTH1R, CALCRL, CALCR | TSHR 108/4885ALDH1A1 4476/4885MAPK1 3859/4885 |
| US-20170101457-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | PTH1R, CALCRL, CALCR | TSHR 108/4885ALDH1A1 4476/4885MAPK1 3859/4885 |
| US-10358471-B2 | Fusion proteins of collagen-binding domain and parathyroid hormone | PTH1R, CALCRL, CALCR | TSHR 108/4885ALDH1A1 4476/4885MAPK1 3859/4885 |
| US-20190338010-A1 | FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE | PTH1R, CALCRL, CALCR | TSHR 108/4885ALDH1A1 4476/4885MAPK1 3859/4885 |
| US-10202434-B2 | Fusion proteins of collagen-binding domain and parathyroid hormone | PTH1R, CALCRL, CALCR | TSHR 108/4885ALDH1A1 4476/4885MAPK1 3859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.